Fig. 2: Correlation between LIMD1-AS1 expression and the clinic-pathologic features of gliomas.
From: Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
A The LIMD1-AS1 expression is shown in GBM vs LGG in CGGA. ***P < 0.001. B The expression of LIMD1-AS1 in different glioma grades. ***P < 0.001. C The expression of LIMD1-AS1 is significantly associated with IDH mutation in CGGA glioma. ***P < 0.001. D Prognostic significance of LIMD1-AS1 in CGGA gliomas. E The LIMD1-AS1 expression is shown in GBM vs LGG in TCGA. ***P < 0.001. F The expression of LIMD1-AS1 in different glioma grades. ***P < 0.001. G The expression of LIMD1-AS1 is significantly associated with IDH mutation in TCGA glioma. *P < 0.05. H, I Prognostic significance of LIMD1-AS1 in gliomas. J The LIMD1-AS1 expression in glioma and normal brain tissues from our cohort. ***P < 0.001. K Relative LIMD1-AS1 in a panel of glioma cell lines and NHA. **P < 0.01.
